To fulfill its responsibilities and to discharge its duty, the Board of Directors follows the procedures and standards that are set forth in these guidelines.
The Board of Directors of Mauna Kea Technologies sets high standards for the Company's employees, officers and directors. Implicit in this philosophy is the importance of sound corporate governance. It is the duty of the Board of Directors to serve as a prudent fiduciary for shareholders and to oversee the management of the Company's business. To fulfill its responsibilities and to discharge its duty, the Board of Directors follows the procedures and standards that are set forth in these guidelines. These guidelines are subject to modification from time to time as the Board of Directors deems appropriate in the best interests of the Company or as required by applicable laws and regulations.
Board of Directors
Christopher D. McFadden
Chairman of the board
Christopher McFadden is the founder of the Canyon Healthcare Partners, an investment fund. Between 2008 and 2013, he was a Managing Partner at Health Evolution Partners, an American healthcare-focused private equity fund. Between 1999 and 2008, he was Senior Financial Analyst at Goldman, Sachs & Co. in New York before heading healthcare-sector investment activities for Goldman Sachs’ Americas Special Situations Group (AmSSG). Mr. McFadden is also a Trustee for Montefiore Medical Center in New York and the Natural History Museum of the Adirondacks.
Jean-Luc Boulnois, Ph.D.
Member of the Board
Jean-Luc Boulnois is the Executive Chairman of the Board at Microline Surgical, an innovative minimally-invasive surgical instrument company with which he has been involved for 18 years as an investor and then, from 2005 to 2013 as CEO, heading a period of uninterrupted growth. He was also CEO of Sometec from 1995 to 1999 and President and COO of Technomed International from 1989 to 1994, two medical technology companies. With French and American dual citizenship, Mr Boulnois has been living in Boston for close to 30 years. He holds a PhD in Aerospace Engineering from Princeton University and an Executive MBA from HEC.
Member of the Board
Joseph DeVivo has been the CEO of AngioDynamics since September 2011. Previously, Mr. DeVivo was CEO and President of RITA Medical Systems. Mr. DeVivo most recently served as Global President of Smith & Nephew Orthopedics. Prior to RITA Medical Systems, Mr. DeVivo served as President, Chief Operating Officer and Director of Computer Motion Incorporation (CMI). Mr. DeVivo previously served as Vice President and General Manager of a $350 million division of TYCO International's Healthcare Business, U.S. Surgical/Davis and Geck Sutures. During his nine-year tenure at U.S. Surgical, he held various management positions related to sales and marketing, supervising numerous product launches and implementing new sales and marketing strategies
Mr. DeVivo earned his Bachelor of Science degree in Business Administration from the E. Clairborne Robins School of Business at the University of Richmond.
Sacha Loiseau, Ph.D.
CEO & Member of the Board
Sacha founded Mauna Kea Technologies in May 2000 and has been the CEO ever since. A co-inventor of the probe-based Confocal Laser Endomicroscopy technology, he piloted the development of the Cellvizio product line, raising over € 32 million with private investors until taking the company public in July 2011 on the NYSE Euronext Paris stock exchange. Mauna Kea's IPO enabled a capital raise of €56.5 million with new investors only and was the largest healthcare IPO in Europe in 2011. In 2013, Sacha was named the co-lead of France's Re-industrialization Plan for Medical Devices by the French President and then a member of the Committee for the Future of Medicine. Sacha sits on the Post-Planning Board at Ecole Polytechnique and has served as a mentor of the Polytechnique-Stanford Ignite Program for young MedTech entrepreneurs for several years. Sacha was instrumental in the foundation of the association Medtech in France, of which he is Vice-President. Sacha is a former board member of Sinequa, a leading enterprise search company. Sacha started his career at the National Center for Space Studies (CNES) in Toulouse and at the Paris Observatory, then joined NASA's Jet Propulsion Laboratory (JPL) in Pasadena, California, as a research scientist. Sacha is a graduate of the École Polytechnique in Paris and has a Ph.D. in Astrophysics and Optical Instrumentation. Sacha is the author of multiple scientific articles and holds 7 international patents.
Marie Meynadier, Ph.D.
Member of the Board
Marie Meynadier is the CEO of EOS Imaging (Euronext: EOSI, FR0011191766). She began her career at the prestigious Bell Labs, and then steered the management of major development programs in France in the fields of electronics, optics and microelectronics, which led to the creation of several start-ups. Marie Meynadier is a graduate of Sup Telecom and has a PhD in Physics from École Normale Supérieure on rue d’Ulm, Paris.
Jennifer F. Tseng, M.D.
Member of the Board
Dr. Tseng received her medical degree from the University of California at San Francisco (UCSF) School of Medicine. She completed her internship and residency in Surgery at Massachusetts General Hospital in Boston, Massachusetts, and a fellowship in Surgical Oncology at MD Anderson Cancer Center in Houston, Texas. Dr. Tseng is Board Certified in General Surgery and is the former Director of the Pancreas Program at the University of Massachusetts Medical School. Dr. Tseng has published and lectured internationally on the diagnosis and treatment of gastrointestinal cancer. Jennifer earned a Masters Degree in Public Health from Harvard University.